What is the prevalence of drug use in the general population? Simulating underreported and unknown use for more accurate national estimates

2022 ◽  
Author(s):  
Natalie S. Levy ◽  
Joseph J. Palamar ◽  
Stephen J. Mooney ◽  
Charles M. Cleland ◽  
Katherine M. Keyes
Keyword(s):  
Drug Use ◽  
General Population ◽  
National Estimates

Frequency of and Determinants for Psychotropic Drug Use in an Institution for the Mentally Retarded

1990 ◽  
Vol 156 (4) ◽  
pp. 525-530 ◽  
Author(s):  
Olav M. Linaker
Keyword(s):  
Drug Use ◽  
General Population ◽  
Psychotropic Drug ◽  
Small Proportion ◽  
Psychiatric Diagnosis ◽  
Anticonvulsant Drug ◽  
Mentally Retarded ◽  
Significant Trend ◽  
Disruptive Behaviour ◽  
Psychiatric Diagnoses

The frequency of psychotropic and anticonvulsant drug use in 168 institutionalised mentally retarded adults was studied. Use of neuroleptics and anticonvulsants was more frequent and use of hypnotics and antidepressants less frequent than in the general population. Neuroleptics were given to 49% of the population. Clients with no psychiatric diagnosis consumed less neuroleptics than those with such a diagnosis, and there was a non-significant trend for those with a more serious diagnosis (e.g. schizophrenia) to take a higher dosage. The degree of disruptive behaviour and the availability of a physician were related to dosage of neuroleptics. The various psychiatric diagnoses given could explain only a small proportion of the variance in dosage.

scholarly journals Epidemiology of illicit and abused drugs in the general population, emergency department drug-related episodes, and arrestees

1996 ◽  
Vol 42 (8) ◽  
pp. 1330-1336 ◽  
Author(s):  
B A Rouse
Keyword(s):  
Emergency Department ◽  
Substance Abuse ◽  
Drug Abuse ◽  
Drug Use ◽  
General Population ◽  
Household Survey ◽  
Data Systems ◽  
General Decline ◽  
Abused Drugs ◽  
National Trends

Abstract National trends in substance abuse are presented: the civilian noninstitutionalized general population; drug-related emergency department episodes; and booked arrestees. Major metropolitan differences are also noted. This study was based on the primary national data systems for these groups: The Substance Abuse and Mental Health Services Administration (SAMHSA) National Household Survey on Drug Abuse, SAMHSA's Drug Abuse Warning Network (DAWN), and the National Institute of Justice Drug Use Forecasting (DUF) system. While the most prevalent drug differed in the three data sources, all three showed recent increases in marijuana. Despite the general decline in drug use seen in the general population, both the number of drug-related cases in the DAWN system and the drug use detected in the DUF arrestees showed recent increases.

Why do People Stop Their Drug Use? Results from a General Population Sample

1999 ◽  
Vol 26 (4) ◽  
pp. 695-710 ◽  
Author(s):  
John A. Cunningham ◽  
Anja Koski-Jännes ◽  
Tony Toneatto
Keyword(s):  
Drug Use ◽  
General Population ◽  
Population Sample ◽  
General Population Sample

The epidemiology of illicit and licit drug use in Greece: a nationwide general population survey

1995 ◽  
Vol 10 (4) ◽  
pp. 175-182 ◽  
Author(s):  
MG Madianos ◽  
D Gefou-Madianou ◽  
CN Stefanis
Keyword(s):  
Drug Use ◽  
General Population ◽  
Illicit Drug ◽  
Occupational Status ◽  
Population Sample ◽  
Age Groups ◽  
Illicit Drug Use ◽  
Total Sample ◽  
General Population Sample ◽  
Cross Sectional

SummaryA cross-sectional home survey on the epidemiology of drug use in Greece, with a nationwide general population sample of 4,291 respondents aged 12 to 64, was carried out. The weighted life prevalence of reported illicit drug use in the total sample was found to be 9% among males and 2.5% among females, with a ratio of 3.6: 1. Six and a half percent of males of all ages had used, at some time, licit psychotropic drugs without a doctor's order, while females presented much higher prevalence rates (14.9%). Young adults reported higher rates of both illicit and licit lifetime and past-year use, compared to the other age groups. Illicit drug use was less common, in females of all ages. Cannabis was the most common illicit drug used. Current as well as lifetime use of pain relievers without a doctor's prescription was found to be highest among all other licit substances. This holds true for all age groups and for both sexes. Tranquillizers were predominantly used by females of all ages. Certain sociodemographic variables, such as sex, educational level, marital status, place of residence and occupational status were found to be related to drug use in Greece.

Illicit drug use in cluster headache patients and in the general population: A comparative cross-sectional survey

Cephalalgia ◽  
2012 ◽  
Vol 32 (14) ◽  
pp. 1031-1040 ◽  
Author(s):  
Paolo Rossi ◽  
Marta Allena ◽  
Cristina Tassorelli ◽  
Grazia Sances ◽  
Cherubino Di Lorenzo ◽  
...  
Keyword(s):  
Drug Use ◽  
General Population ◽  
Cluster Headache ◽  
Illicit Drug ◽  
Illicit Drug Use ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Headache Patients

Cardiovascular drug use and mortality in patients with schizophrenia or bipolar disorder: a Danish population-based study

2013 ◽  
Vol 44 (8) ◽  
pp. 1625-1637 ◽  
Author(s):  
T. M. Laursen ◽  
P. B. Mortensen ◽  
J. H. MacCabe ◽  
D. Cohen ◽  
C. Gasse
Keyword(s):  
Risk Factors ◽  
Bipolar Disorder ◽  
Drug Use ◽  
General Population ◽  
Cerebrovascular Disease ◽  
Severity Of Illness ◽  
Population Based ◽  
Danish Population ◽  
Co Morbidity ◽  
Rate Ratios

BackgroundCardiovascular (CV) co-morbidity is one of the major modifiable risk factors driving the excess mortality in individuals with schizophrenia or bipolar disorder. Population-based studies in this area are sparse.MethodWe used Danish population registers to calculate incidence rate ratios (IRRs) for CV drug use, and mortality rate ratios comparing subjects with schizophrenia or bipolar disorder with subjects with no prior psychiatric hospitalization.ResultsIRRs for CV prescriptions were significantly decreased in patients with schizophrenia or bipolar disorder compared with the general population. Among persons without previous myocardial infarction (MI) or cerebrovascular disease, persons with schizophrenia or bipolar disorder had an up to 6- and 15-fold increased mortality from all causes or unnatural causes, respectively, compared with the general population, being most pronounced among those without CV treatment (16-fold increase). Among those with previous MI or cerebrovascular disease, excess all-cause and unnatural death was lower (up to 3-fold and 7-fold increased, respectively), but was similar in CV-treated and -untreated persons.ConclusionsThe present study shows an apparent under-prescription of most CV drugs among patients with schizophrenia or bipolar disorder compared with the general population in Denmark. The excess of mortality by unnatural deaths in the untreated group suggests that the association between CV treatment and mortality may be confounded by severity of illness. However, our results also suggest that treatment of CV risk factors is neglected in these patients.

scholarly journals Harm Experienced from the Heavy Drinking of Family and Friends in the General Population: A Comparative Study of Six Northern European Countries

2015 ◽  
Vol 9s2 ◽  
pp. SART.S23746 ◽  
Author(s):  
Mats Ramstedt ◽  
Erica Sundin ◽  
Inger Synnøve Moan ◽  
Elisabet E. Storvoll ◽  
Ingunn Olea Lund ◽  
...  
Keyword(s):  
General Population ◽  
Heavy Drinking ◽  
Future Research ◽  
Northern European ◽  
Gender And Age ◽  
Full Picture ◽  
National Estimates ◽  
Alcohol Related Harm ◽  
Related Harm ◽  
Related Mortality

Background Epidemiological research on alcohol-related harm has long given priority to studies on harm to the drinker. A limitation with this perspective is that it neglects the harm drinking causes to people around the drinker, and thus, it fails to give a full picture of alcohol-related harm in society. Aim The aim was to compare the prevalence and correlates of experiencing harm from the heavy drinking by family and friends across the Nordic countries and Scotland and to discuss whether potential differences match levels of drinking, prevalence of binge drinking, and alcohol-related mortality. Data and Method Data from recent national general population surveys with similar questions on experiences of harms from the drinking of family and friends were collected from Sweden, Finland, Denmark, Norway, Iceland, and Scotland. Results National estimates of the overall population prevalence of harm from the drinking of family and friends ranged from 14% to 28% across these countries, with the highest prevalence in Finland, Iceland, and Norway and lower estimates for Denmark, Sweden, and Scotland. Across all countries, the prevalence of harm from heavy drinking by family and friends was significantly higher among women and young respondents. Conclusion This study revealed large differences in the prevalence of harm across the study countries, as well as by gender and age, but the differences do not match the variation in population drinking and other indicators of harm. The implications of the findings for future research are discussed.

Sign in / Sign up

Export Citation Format

Share Document